Phenindamine tartrate
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313434This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19N.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 28725X3PV8, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridine l-(+)-tartrate (1:1) but more generally known as phenindamine tartrate, which bears US NIH Compound Identifier 11290. European Medicines Agency schedules Phenindamine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03745MIG. Most nations, for tariff and trade purposes, schedule phenindamine tartrate under HS 29339920 and SITC 51577. As of Q4 2014, PHENINDAMINE TARTRATE remains US FDA's Preferred Term for this commodity. Phenindamine tartrate bears US NLM identifiers UMLS ID C0724658 and NCI Concept Code C87746. SMILES: CN1CCC2=C(C1)C(C3C2CCCC3)C4CCCCC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.